Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
0.5255
-0.0199 (-3.65%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Veru Inc. Market Cap

Veru Inc. has a market cap or net worth of $78.20 million as of April 17, 2025. Its market cap has decreased by -35.59% in one year.

Market Cap
78.20M
Enterprise Value
55.51M
1-Year Change
-35.59%
Ranking
Category
Stock Price
$0.53

Market Cap Chart

Since February 11, 1999, Veru Inc.'s market cap has increased from $17.00M to $78.20M, an increase of 359.99%. That is a compound annual growth rate of 6.00%.

History

DateMarket Cap% Change
Apr 17, 202578.20M-17.77%
Dec 31, 202495.10M41.10%
Dec 29, 202367.40M-84.17%
Dec 30, 2022425.70M-9.69%
Dec 31, 2021471.40M-22.24%
Dec 31, 2020606.20M178.20%
Dec 31, 2019217.90M148.46%
Dec 31, 201887.70M44.48%
Dec 29, 201760.70M112.98%
Dec 30, 201628.50M-32.30%
Dec 31, 201542.10M-62.74%
Dec 31, 2014113.00M-53.73%
Dec 31, 2013244.20M18.60%
Dec 31, 2012205.90M63.80%
Dec 30, 2011125.70M-19.63%
Dec 31, 2010156.40M24.42%
Dec 31, 2009125.70M30.39%
Dec 31, 200896.40M38.31%
Dec 31, 200769.70M85.87%
Dec 29, 200637.50M-7.64%
Dec 30, 200540.60M-11.74%
Dec 31, 200446.00M-14.34%
Dec 31, 200353.70M88.42%
Dec 31, 200228.50M139.50%
Dec 31, 200111.90M80.30%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 679.94B
UnitedHealth Group 533.82B
Johnson & Johnson 370.20B
AbbVie 312.76B
Novo Nordisk 286.28B
Abbott Laboratories 218.91B
AstraZeneca 210.97B
Novartis AG 209.02B
Market Cap Rankings